Abstract
Objective: This study assessed the factors associated with delayed referral to a nephrologist and delay in formation of a permanent vascular access in incident hemodialysis (HD) patients.
Methods: This prospective cross-sectional study was conducted from February 2021 to July 2021 on end stage renal disease (ESRD) patients receiving maintenance hemodialysis (MHD) at our center. Data were collected at the bedside during the HD session about a referral to a nephrologist, about when they were asked for permanent vascular access formation and the reason for the delay in its formation.
Results: Out of 296 patients recruited in our study, 168 (56.8%) were male and 128 (43.2) were female. The mean age was 53.5±15 years (minimum of 19 years and maximum of 90 years). The most common reason for refusal of making permanent vascular access [arterio-venous fistula (AVF) or arterio-venous graft (AVG)] was fear of pain in our patients 65 (43.3%) followed by the denial of the disease 32 (21.3%). Among the study subjects, 231 (78%) patients were referred to the nephrologist immediately or within one month of their diagnosis. Some 152 (51.4%) of the patients were not in favor of making AVF whereas 151 (51%) refused for starting HD, hence most of our patients 181 (61.1%) initiated HD in emergency by a central venous catheter (CVC).
Conclusion: Early referral should be done by primary care physicians (PCPs) for the timely management of CKD patients. As CKD is a progressive disease, it requires special attention by a nephrologist for adjustment of patient’s medications, timely follow-up, counseling, the early formation of AVF for HD, and planning for renal transplant. In our study, the majority of our patients initiated their HD via CVC because of the delayed visit to a nephrologist. Most patients were asked for AVF formation on the same day of presentation to our nephrology unit as they had advanced CKD (Stage 5) 134 (51.4%). Most patients in our study delayed AVF formation 152 (51.4%). With timely referral to a nephrologist, the nephrologist will be able to do better and repeated counseling about the disease, its progression, and the need for permanent vascular access for initiation of HD while patients and their families will get more time to make decisions.
Keywords: delayed refferal, maintenance hemodialysis, hemodialysis access, arteriovenous graft, arterio-venous fistula, central venous catheter (cvc)
Introduction
Chronic kidney disease (CKD) is a leading cause of mortality and morbidity globally [1]. The burden of CKD is increasing in South East Asia and in Pakistan [2]. Awareness of CKD is limited, not only among the general population but referring physicians too, thereby increasing the need for hospitalization and mortality [3]. Around 25%-40% of CKD patients need renal replacement therapy (RRT) in the form of dialysis or renal transplant, soon after referral to a nephrologist, which leads to higher morbidity, mortality, hospital admissions, and worse long-term survival [4].
Vascular access is fundamental for carrying out hemodialysis (HD). There are three main types of vascular access: native arteriovenous fistula (AVF), arteriovenous graft (AVG), and central venous catheter (CVC), which includes tunneled CVC (tCVC) and non-tunneled CVC (ntCVC) [5]. The National Kidney Foundation-Kidney Disease Outcomes Quality Initiative (KDOQI) clinical practice guidelines for vascular access suggest that an AVF or an AVG is preferred to a CVC in most incident and prevalent HD patients due to the lower infection risk [6]. AVF is associated with lower mortality and morbidity [7-8].
The KDOQI also recommends an early formation of AVF when compared to AVG in incident HD patients to prevent vascular complications, like thrombosis, loss of primary patency, and interventions [6]. Incident HD patients with continuous use of CVC as their access experience reduced social life, poor sleep and energy, impact on daily routine, and reduced quality of life [9]. CKD patients showed more satisfaction with AVF as compared to other vascular access [10].
Most countries use CVC in more than 50% of the patients on initiating HD due to lack of patient’s knowledge of their disease, non-compliance to follow up, uncertain clinical presentation, and delayed referrals [11-12]. The incidence of CVC use is higher at the initiation of HD and the morbidity and mortality rate remains high in these patients [13]. Hence every effort should be made for the early formation of AVF. Primary care physicians (PCPs) refer CKD patients late to the nephrologist, which causes a delay in vascular access formation, initiation of HD with CVC, and delay in renal transplant [14-15].
This study was done to determine the frequency of CVC (ntCVC and tCVC) before permanent vascular access (AVG, AVF) is made, the time of referral to a nephrologist, and the reason behind the delay. This will help PCPs to understand that timely referral of CKD patients to a nephrologist is crucial for proper management, in choosing dialysis modality, counseling for permanent vascular access formation, and decision regarding renal transplant.
Materials and methods
This prospective cross-sectional study was done at The Kidney Centre Postgraduate Training Institute, Karachi, Pakistan (TKC-PGTI) from February 2021 to July 2021 after approval from the hospital ethical review committee (TKC-ERC reference No. 113-NEPH-122020). Participants included in this study were adult end stage renal disease (ESRD) patients on maintenance hemodialysis (MHD) at our center, who willingly participated in the study by signing a written informed consent. Patients who received HD for acute kidney injury (AKI) and those with functioning renal transplant were excluded.
Data were collected on a pre-formed proforma, including age, gender, marital status, occupation, education, socioeconomic status, vascular access use at the time of initiation of HD, (tCVC, ntCVC, AVF, or AVG), and the reason behind the delay in getting permanent vascular access (AVF or AVG). The patients were asked about the time of diagnosis of CKD by PCP and when they were referred to a nephrologist after diagnosis.
Data were analyzed on IBM SPSS version 21 (SPSS Inc., Chicago, IL). Mean ± standard deviation was calculated for normally distributed continuous variables. Shapiro Wilk’s test checked the normality of data. Association of demographic and clinical variables with delay in the making of permanent access was established by chi-square test. The significant level was set as ≤ 0.05.
Results
A total of 296 patients with a male to female ratio of 1.3:1 [males were 168 (56.8%) and females were 12 (43.2%)] participated in the study. The mean age of our study patients was 53.5±15 years (minimum of 19 years and maximum of 90 years). The majority of the study patients were married 260 (87.8%), while most patients 102(34.5%) were educated up to the primary level. Most of the male participants were unemployed 109(36.8%), while most of the female participants were stay-at-home mothers 109(36.8%). Most patients had a household income of PKR 50,000-100,000/month (300-600 USD) 107(36.1%). The most common comorbid in the study cohort was hypertension 284(95.9%) followed by diabetes mellitus 127(42.9%) (Table 1).
Table 1. Baseline characteristics of study patients (n= 296).
ESRD, end-stage renal disease
| Variables | n (%) | |
| Gender | Male | 168(56.8) |
| Female | 128(43.2) | |
| Marital status | Single | 36(12.2) |
| Married | 260(87.8) | |
| Education | Uneducated | 67(22.6) |
| Primary | 102(34.5) | |
| Intermediate | 29(9.8) | |
| Graduate | 77(26) | |
| Post-graduate | 21(7.1) | |
| Employment status | Non-working | 109(36.8) |
| House wife | 109(36.8) | |
| On job | 46(15.5) | |
| Retired | 32(10.8) | |
| Monthly household income PKR (USD) | <25000 (<150) | 35(11.8) |
| 25000-50000 (150-300) | 132(44.6) | |
| 51000-100,000 (300-600) | 107(36.1) | |
| >100,000 (> 600) | 22(7.4) | |
| Comorbid conditions | Hypertension | 284(95.9) |
| Diabetes mellitus | 127(42.9) | |
| Ischemic heart disease | 45(15.2) | |
| Hepatitis | 49(16.2) | |
| Hypothyroidism | 18(6.1) | |
| Asthma | 8(2.7) | |
| Cerebrovascular accident | 5(1.7) | |
| Benign prostate hypertrophy | 5(1.7) | |
| Cause of ESRD | Unknown (CKDu) | 128(42.3) |
| Diabetic nephropathy | 118(39.9) | |
| Glomerulonephritis | 32(10.8) | |
| Renal stone disease | 8(2.7) | |
| Adult polycystic kidney disease | 8(2.7) | |
| Reflux nephropathy | 1(0.3) | |
| Bilateral nephrectomy | 1(0.3) | |
The most common reason for refusing permanent vascular access was fear of pain in our study participants 65(43.3%) followed by the denial of the disease 32(21.3%) (Table 2).
Table 2. Reasons of refusal of permanent access formation n (%).
| Reasons of refusal | n (%) |
| Fear of pain | 65(43.3) |
| Denial of disease | 32(21.3) |
| Lifestyle disruption | 16(10.7) |
| Bad experience of others | 11(7.3) |
| Financial burden | 10(6.7) |
| Lack of symptoms | 5(2.3) |
| Family pressure | 5(2.3) |
| Lack of vascular access knowledge | 3(2) |
| Vascular tissue | 2(1.3) |
| Dependency | 1(0.7) |
In the majority, the general physician made the diagnosis of ESRD 240 (81.1%). Most patients were referred to a nephrologist immediately or within one month of diagnosis 231(78%). The majority of the patients were asked for AVF formation on the same day of presentation to our nephrology unit as they have advanced CKD (Stage 5) 134(51.4%). Most of these patients were not in favor of making AVF or starting MHD 152(51.4%) and 151(51%) respectively, therefore, in the majority of patients, HD was initiated in the emergency department by the tCVC 181(61.1%) (Table 3).
Table 3. Parameters for initiation of HD n (%).
ESRD, end-stage renal disease; HD, hemodialysis; AVF, arterio-venous fistula; CVC, central venous catheter
| Variables | n (%) | |
| Diagnosis of ESRD made by | General physician | 240(81.1) |
| Nephrologist | 31(10.5) | |
| Other specialist | 22(7.4) | |
| None | 3(1) | |
| Time of referral to nephrologist after diagnosis | Within 1 month | 231(78) |
| 1 month-1 year | 30(10.1) | |
| Self-referred | 35(11.8) | |
| When patient was asked to get permanent access | Same day | 134(45.3) |
| 1 month-1 year | 70(23.6) | |
| 1-5 years | 71(24) | |
| > 5 years | 21(7.1) | |
| Willingness for permanent access formation | No | 152(51.4) |
| Yes | 144(48.6) | |
| Willingness for initiation of HD | No | 151(51) |
| Yes | 145(49) | |
| Initiation of HD done in | Emergency | 181(61.1) |
| Elective | 115(28.9) | |
| Hemodialysis initiated by | AVF | 115(38.4) |
| CVC | 181(61.1) | |
| Time of delay in making permanent vascular access | No delay | 122(41.2) |
| 1-3 months | 78(26.4) | |
| 4-6 months | 56(18.9) | |
| 7 months-1 year | 25(8.4) | |
| > 1 year | 15(5.1) |
Age was significantly associated with delay in the formation of permanent access for MHD (p=0.018). Patients between ages 41 and 60 years did not delay AVF formation 72(59%) as compared to other age groups. Most unmarried patients got AVF earlier 26(72.7%) as compared to married patients, although the p-value was not significant (p= 0.08) (Table 4).
Table 4. Association of baseline factors of patients with delay in permanent access formation.
| Factors of patients for delay in permanent access formation | Delay in permanent access formation | p value | |||
| No=122(41.2%) | Yes =174(58.8%) | ||||
| Age of patients | ≤ 40 years | 18(27.7) | 47(72.3) | 0.018 | |
| 41 to 60 years | 50(41) | 72(59) | |||
| > 60 years | 54(49.5) | 55(50.5) | |||
| Gender | Male | 72(42.9) | 46(57.1) | 0.511 | |
| Female | 50(39.1) | 78(60.9) | |||
| Marital status | Single | 10(27.8) | 26(72.2) | 0.08 | |
| Married | 112(43.1) | 148(56.9) | |||
| Education | Uneducated | 30(44.8) | 37(55.2) | 0.275 | |
| ≤ Secondary | 36(35.3) | 66(64.7) | |||
| Intermediate | 9(31) | 20(69) | |||
| Graduation | 36(46.8) | 41(53.2) | |||
| Post-graduation | 11(52.4) | 10(47.6) | |||
| Employment status | Non-working | 41(37.6) | 68(62.4) | 0.46 | |
| Stay home mother | 44(40.4) | 65(59.6) | |||
| On job | 20(43.5) | 26(56.5) | |||
| Retired | 17(53.1) | 15(46.9) | |||
| Monthly household income in PKR (USD) | < 25000 (<150) | 14(40) | 21(60) | 0.31 | |
| 25000-50000 (150-300) | 55(41.7) | 77(58.3) | |||
| 51000-100,000 (300-600) | 40(37.4) | 67(62.6) | |||
| >100,000 (>600) | 13(59.1) | 9(40.9) | |||
Discussion
As CKD patients have been increasing globally, the need for RRT is increasing. Timely referral to a nephrologist is essential for planning drug adjustment, lifestyle modifications, selection of modality of dialysis, vascular access formation for HD, initiation of dialysis, and decision about renal transplant. The KDIGO guidelines advise that the CKD patients should be referred to a nephrologist once the glomerular filtration rate (GFR) falls below 30 mL/min, but in many cases, the decision to initiate dialysis depends on patient’s symptoms like uremic encephalopathy, hyperkalemia, fluid overload, irrespective of the GFR [6,16].
Lack of symptoms, lack of awareness of the disease, fear of pain, denial of the disease, financial burden, and lifestyle disruption are the major patient-related factors [3], while lack of communication, poor working relationships, treating CKD patients on their own are physicians’ related factors in delayed referral to a nephrologist [17].
In our study, most patients were referred by general physicians 240 (81.1%). Among these patients, most visited a nephrologist first time when they already had CKD Stage 5. The majority were asked for permanent vascular access formation on the day of their first visit to a nephrologist 134 (45.3%). This delayed referral to a nephrologist was observed in many studies globally. Recently Dharod et al. reviewed records of 133,913 patients on follow-up by 185 primary care practices (61 practices). Out of these, 54.6% were not referred to nephrology [18]. Alfarhan et al. found that the most important physician and hospital factors are insufficient conduction of pre-dialysis care and education (63.7%) and late referral to a nephrologist (56.6%) [19].
Most of our study patients did not favor vascular access formation or the initiation of HD when diagnosed with ERSD 152(51.4%). The most common factor for refusal of permanent access formation was fear of pain in our study 65(43.3%), while 32(21.3%) denied their disease. Our results are similar to the study done by Alfarhan et al. [19] which showed denial in 76.4% and fear 75.9% as major causes of delay in permanent vascular access formation.
Most of our study participants started HD in emergency via ntCVC 181(61.1%). Most of them delayed permanent vascular access formation for one to three months 78(26.4%) despite repeated counseling, while 56(18.9%) delayed it for four to six months. Similar results were found in a study done in Pakistan; it showed that 80% required CVC as their first access for MHD (96/120 patients), out of which 74.2% were dialyzed through ntCVC and 5.8% through tCVC [20].
Kim et al. concluded that 73.3% of CKD patients started dialysis with CVC, whereas 21.5% with AVF and 5.2% with AVG. The patients who initiated HD with AVF had a better outcome, high quality of life, low incidence of depression, and reduced hospitalization rate [7]. Locham et al. found that after adjusting for potential confounders, compared to AVF, patients with AVG [HR(95% CI): 1.35(1.31-1.40)] and HD using catheters (HC) [HR(95% CI): 1.80(1.77-1.84)] were more likely to develop sepsis at three years (both P < 0.001) [21].
Among all variables, age and marital status showed statistical significance in our study. Younger and older patients refused AVF more in comparison to middle age. Kim et al. found increased five-year mortality in association with CVC in CKD patients aged 65-74 or ≥ 75 years, as compared to <65 years [7]. Most of our married patients delayed AVF formation 148(56.9%) (P = 0.08). This could be a bias as the number of married patients was high as compared to unmarried in our study. Delay in AVF among married patients may be associated with family pressure.
A high level of satisfaction has been associated with the use of permanent vascular access, mainly with AVF in HD patients, which improves the quality of life and reduces mortality. Wasse et al. evaluated access use satisfaction in HD patients; out of 77 patients, 62.3% used AVF and were the most satisfied as compared to patients with tCVC 23.4% and AVG 14.3% [22].
Our study has a few limitations. It is a single-center study of MHD patients. The majority of the study patients were referred by PCPs late and at the time of need of initiation of HD. For this reason, most patients were asked to get AVF on their first visit, a decision of which was difficult for patients and their families for various reasons, including fear of pain and denial of the disease, leading to further delay in AVF formation. We did not compare the study cohort with patients on regular follow-up with our nephrology department.
Conclusions
As CKD is a chronic progressive disease with high and rising incidence worldwide, awareness of the disease process is very important for CKD patients and their families by repeated counseling. PCPs should be more aware of early CKD diagnosis and should refer the CKD patients to a nephrologist early for drug adjustment, counseling, early permanent vascular access formation, and early planning of renal transplant. Early referral also helps in reduced use of CVC and hospitalization secondary to CVC-related complications.
The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.
The authors have declared that no competing interests exist.
Human Ethics
Consent was obtained or waived by all participants in this study. The Kidney Centre Ethical Review Committee issued approval TKC-ERC reference No. 113-NEPH-122020. Dear Dr. Natasha Khatri, Your submission Reference No. 113-NEPH-122020, titled “Delay in Permanent Access Formation and Referral to A Nephrologist in Incident Hemodialysis Patients”, is approved by TKC-ERC. This approval is valid for 1 year with effect from 18.02.2021. For the continuation of project in the next years, you have to send a progress report and a formal request asking for continuation of project. Kindly keep the TKC-ERC, updated about the progress of the project and submit the formal final report on completion.
Animal Ethics
Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.
References
- 1.The impact of chronic kidney disease on global health. Carney EF. Nat Rev Nephrol. 2020;16:251. doi: 10.1038/s41581-020-0268-7. [DOI] [PubMed] [Google Scholar]
- 2.Burden of chronic kidney disease in the general population and high-risk groups in South Asia: a systematic review and meta-analysis. Shrestha N, Gautam S, Mishra SR, Virani SS, Dhungana RR. PLoS One. 2021;16:0. doi: 10.1371/journal.pone.0258494. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.CKD awareness in the general population: performance of CKD-specific questions. Tuot DS, Wong KK, Velasquez A, Crews DC, Zonderman AB, Evans MK, Powe NR. Kidney Med. 2019;1:43–50. doi: 10.1016/j.xkme.2019.01.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Late referral to a nephrologist reduces access to renal transplantation. Cass A, Cunningham J, Snelling P, Ayanian JZ. Am J Kidney Dis. 2003;42:1043–1049. doi: 10.1016/j.ajkd.2003.07.006. [DOI] [PubMed] [Google Scholar]
- 5.Vascular access for hemodialysis: current perspectives. Santoro D, Benedetto F, Mondello P, et al. Int J Nephrol Renovasc Dis. 2014;7:281–294. doi: 10.2147/IJNRD.S46643. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Clinical practice guidelines for vascular access. Vascular Access 2006 Work Group. Am J Kidney Dis. 2006;48:0. [Google Scholar]
- 7.The effects of vascular access types on the survival and quality of life and depression in the incident hemodialysis patients. Kim DH, Park JI, Lee JP, et al. Ren Fail. 2020;42:30–39. doi: 10.1080/0886022X.2019.1702558. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Trends in incident hemodialysis access and mortality. Malas MB, Canner JK, Hicks CW, et al. JAMA Surg. 2015;150:441–448. doi: 10.1001/jamasurg.2014.3484. [DOI] [PubMed] [Google Scholar]
- 9.Initiation of maintenance hemodialysis through central venous catheters: study of patients' perceptions based on a structured questionnaire. Tang TT, Levin ML, Ahya SN, Boobes K, Hasan MH. BMC Nephrol. 2019;20:270. doi: 10.1186/s12882-019-1422-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.The associations of hemodialysis access type and access satisfaction with health-related quality of life. Domenick Sridharan N, Fish L, Yu L, Weisbord S, Jhamb M, Makaroun MS, Yuo TH. J Vasc Surg. 2018;67:229–235. doi: 10.1016/j.jvs.2017.05.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Patient education and care for end-stage kidney disease: one size never fits all. Oh KH. https://pubmed.ncbi.nlm.nih.gov/33303726/ Kidney Res Clin Pract. 2020;39:384–386. doi: 10.23876/j.krcp.20.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Catheter first: the reality of incident hemodialysis patients in the United States. Packer D, Kaufman JS. Kidney Med. 2020;2:242–244. doi: 10.1016/j.xkme.2020.04.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Evolution of vascular access use among incident patients during the first year on hemodialysis: a national cohort study. Wael F. Hussein, Gasim Ahmed, Leonard D, et al. Kidney360. 2021;2:955–965. doi: 10.34067/KID.0006842020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Outcome of chronic kidney disease patients on the basis of referral to nephrologist: a one-year follow-up study. Anees M, Hussain Y, Ibrahim M, Ilahi I, Ahmad S, Asif KI, Jameel A. https://pubmed.ncbi.nlm.nih.gov/29615173/ J Coll Phys Surg Pak. 2018;28:304–307. doi: 10.29271/jcpsp.2018.04.304. [DOI] [PubMed] [Google Scholar]
- 15.Not early referral but planned dialysis improves quality of life and depression in newly diagnosed end stage renal disease patients: a prospective cohort study in Korea. Park JI, Kim M, Kim H, et al. PLoS One. 2015;10:0. doi: 10.1371/journal.pone.0117582. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Chronic kidney disease diagnosis and management: a review. Chen TK, Knicely DH, Grams ME. JAMA. 2019;322:1294–1304. doi: 10.1001/jama.2019.14745. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Primary care physicians' perceived barriers to nephrology referral and co-management of patients with CKD: a qualitative study. Greer RC, Liu Y, Cavanaugh K, et al. J Gen Intern Med. 2019;34:1228–1235. doi: 10.1007/s11606-019-04975-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Primary care referrals to nephrology in patients with advanced kidney disease. Dharod A, Bundy R, Russell GB, Rice WY 3rd, Golightly CE, Rosenthal GE, Freedman BI. Am J Manag Care. 2020;26:468–474. doi: 10.37765/ajmc.2020.88526. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Causes of the delay in creating permanent vascular access in hemodialysis patients. Alfarhan MA, Almatrafi SA, Alqaseer SM, Albkiry YA, AlSayyari A. Saudi J Kidney Dis Transpl. 2020;31:1217–1224. doi: 10.4103/1319-2442.308330. [DOI] [PubMed] [Google Scholar]
- 20.Pre dialysis care and types of vascular access employed in incident hemodialysis patients: a study from Pakistan. Nasir Mahmood S, Naveed Mukhtar K, Iqbal N, Umair SF. Pak J Med Sci. 2013;29:828–831. doi: 10.12669/pjms.293.3385. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Incidence and risk factors of sepsis in hemodialysis patients in the United States. Locham S, Naazie I, Canner J, Siracuse J, Al-Nouri O, Malas M. J Vasc Surg. 2021;73:1016–1021. doi: 10.1016/j.jvs.2020.06.126. [DOI] [PubMed] [Google Scholar]
- 22.Predictors of delayed transition from central venous catheter use to permanent vascular access among ESRD patients. Wasse H, Speckman RA, Frankenfield DL, Rocco MV, McClellan WM. Am J Kidney Dis. 2007;49:276–283. doi: 10.1053/j.ajkd.2006.11.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
